Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 01, 2020 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 24,783 | $2.52 | 363,547 | |
| Dec 01, 2020 | Director, Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 24,783 | $22.77 | 338,764 | |
| Dec 01, 2020 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 24,783 | -- | 10,653 | |
| May 11, 2015 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 24,800 | $10.84 | 6,575 | |
| May 11, 2015 | Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 24,800 | $10.84 | 6,575 | |
| Jun 01, 2018 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $16.72 | 396,771 | |
| May 16, 2018 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $15.00 | 421,771 | |
| Feb 07, 2017 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $6.00 | 534,266 | |
| Jan 13, 2017 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $6.00 | 559,266 | |
| Nov 01, 2016 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $7.00 | 533,453 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.